794 related articles for article (PubMed ID: 24746665)
1. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
[TBL] [Abstract][Full Text] [Related]
2. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years.
Suardi N; Ficarra V; Willemsen P; De Wil P; Gallina A; De Naeyer G; Schatteman P; Montorsi F; Carpentier P; Mottrie A
Urology; 2012 Jan; 79(1):133-8. PubMed ID: 22088567
[TBL] [Abstract][Full Text] [Related]
3. Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience.
Busch J; Stephan C; Herold A; Erber B; Kempkensteffen C; Hinz S; Lein M; Weikert S; Miller K; Magheli A
BJU Int; 2012 Dec; 110(11 Pt C):E985-90. PubMed ID: 22672442
[TBL] [Abstract][Full Text] [Related]
4. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
5. Open vs. robotic-assisted radical prostatectomy: a single surgeon and pathologist comparison of pathologic and oncologic outcomes.
Masterson TA; Cheng L; Boris RS; Koch MO
Urol Oncol; 2013 Oct; 31(7):1043-8. PubMed ID: 22222059
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
[TBL] [Abstract][Full Text] [Related]
7. Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up.
Murphy DG; Kerger M; Crowe H; Peters JS; Costello AJ
Eur Urol; 2009 Jun; 55(6):1358-66. PubMed ID: 19147274
[TBL] [Abstract][Full Text] [Related]
8. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
Barocas DA; Salem S; Kordan Y; Herrell SD; Chang SS; Clark PE; Davis R; Baumgartner R; Phillips S; Cookson MS; Smith JA
J Urol; 2010 Mar; 183(3):990-6. PubMed ID: 20083261
[TBL] [Abstract][Full Text] [Related]
9. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
[TBL] [Abstract][Full Text] [Related]
10. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
[TBL] [Abstract][Full Text] [Related]
11. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy.
Ploussard G; de la Taille A; Moulin M; Vordos D; Hoznek A; Abbou CC; Salomon L
Eur Urol; 2014 Mar; 65(3):610-9. PubMed ID: 23245815
[TBL] [Abstract][Full Text] [Related]
14. Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: experience from Australasia.
Cathcart P; Murphy DG; Moon D; Costello AJ; Frydenberg M
BJU Int; 2011 Apr; 107 Suppl 3():11-9. PubMed ID: 21492370
[TBL] [Abstract][Full Text] [Related]
15. A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.
Silberstein JL; Su D; Glickman L; Kent M; Keren-Paz G; Vickers AJ; Coleman JA; Eastham JA; Scardino PT; Laudone VP
BJU Int; 2013 Feb; 111(2):206-12. PubMed ID: 23356747
[TBL] [Abstract][Full Text] [Related]
16. Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes.
Ledezma RA; Negron E; Razmaria AA; Dangle P; Eggener SE; Shalhav AL; Zagaja GP
World J Urol; 2015 Nov; 33(11):1689-94. PubMed ID: 25701128
[TBL] [Abstract][Full Text] [Related]
17. The addition of robotic surgery to an established laparoscopic radical prostatectomy program: effect on positive surgical margins.
Trabulsi EJ; Linden RA; Gomella LG; McGinnis DE; Strup SE; Lallas CD
Can J Urol; 2008 Apr; 15(2):3994-9. PubMed ID: 18405448
[TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
19. Positive surgical margins after minimally invasive radical prostatectomy in patients with pT2 and pT3a disease could be considered pathological upstaging.
Ouzzane A; Rozet F; Salas RS; Galiano M; Barret E; Prapotnich D; Cathelineau X
BJU Int; 2014 Apr; 113(4):586-91. PubMed ID: 23889763
[TBL] [Abstract][Full Text] [Related]
20. Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious.
Lavery HJ; Nabizada-Pace F; Carlucci JR; Brajtbord JS; Samadi DB
Urol Oncol; 2012; 30(1):26-32. PubMed ID: 20189844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
